JP2023156365A5 - - Google Patents

Download PDF

Info

Publication number
JP2023156365A5
JP2023156365A5 JP2023122299A JP2023122299A JP2023156365A5 JP 2023156365 A5 JP2023156365 A5 JP 2023156365A5 JP 2023122299 A JP2023122299 A JP 2023122299A JP 2023122299 A JP2023122299 A JP 2023122299A JP 2023156365 A5 JP2023156365 A5 JP 2023156365A5
Authority
JP
Japan
Prior art keywords
cell
protein
linker
fusion protein
nuclear localization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023122299A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023156365A (ja
Filing date
Publication date
Priority claimed from JP2021547390A external-priority patent/JP2022520104A/ja
Application filed filed Critical
Publication of JP2023156365A publication Critical patent/JP2023156365A/ja
Publication of JP2023156365A5 publication Critical patent/JP2023156365A5/ja
Pending legal-status Critical Current

Links

JP2023122299A 2019-02-15 2023-07-27 Crispr/cas融合タンパク質およびシステム Pending JP2023156365A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962806708P 2019-02-15 2019-02-15
US62/806,708 2019-02-15
JP2021547390A JP2022520104A (ja) 2019-02-15 2020-02-13 Crispr/cas融合タンパク質およびシステム
PCT/US2020/018145 WO2020168102A1 (en) 2019-02-15 2020-02-13 Crispr/cas fusion proteins and systems

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021547390A Division JP2022520104A (ja) 2019-02-15 2020-02-13 Crispr/cas融合タンパク質およびシステム

Publications (2)

Publication Number Publication Date
JP2023156365A JP2023156365A (ja) 2023-10-24
JP2023156365A5 true JP2023156365A5 (cg-RX-API-DMAC10.html) 2024-04-26

Family

ID=70166116

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021547390A Pending JP2022520104A (ja) 2019-02-15 2020-02-13 Crispr/cas融合タンパク質およびシステム
JP2023122299A Pending JP2023156365A (ja) 2019-02-15 2023-07-27 Crispr/cas融合タンパク質およびシステム

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021547390A Pending JP2022520104A (ja) 2019-02-15 2020-02-13 Crispr/cas融合タンパク質およびシステム

Country Status (11)

Country Link
US (3) US10947517B2 (cg-RX-API-DMAC10.html)
EP (1) EP3924475A1 (cg-RX-API-DMAC10.html)
JP (2) JP2022520104A (cg-RX-API-DMAC10.html)
KR (1) KR20210139271A (cg-RX-API-DMAC10.html)
CN (1) CN113728099A (cg-RX-API-DMAC10.html)
AU (2) AU2020221274B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021016019A2 (cg-RX-API-DMAC10.html)
CA (1) CA3129835A1 (cg-RX-API-DMAC10.html)
IL (1) IL285300A (cg-RX-API-DMAC10.html)
SG (1) SG11202108812SA (cg-RX-API-DMAC10.html)
WO (1) WO2020168102A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
SG11202108812SA (en) 2019-02-15 2021-09-29 Sigma Aldrich Co Llc Crispr/cas fusion proteins and systems
KR20260037664A (ko) * 2021-09-08 2026-03-18 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 게놈을 조절하기 위한 방법 및 조성물
CN116063546B (zh) * 2021-10-29 2026-01-16 中科辅酶医科技(深圳)有限公司 一种基于共振能量转移的全遗传编码nad+蛋白探针及其制备方法和应用
US20230265405A1 (en) * 2022-02-22 2023-08-24 Massachusetts Institute Of Technology Engineered nucleases and methods of use thereof
AU2023232138A1 (en) * 2022-03-08 2024-09-26 Wake Forest University Health Sciences Compositions, systems and methods for eukaryotic gene editing
WO2025221793A1 (en) * 2024-04-16 2025-10-23 Monsanto Technology Llc Modified cas proteins for nuclear localization and editing activity in plants

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232430A1 (en) 2001-11-26 2003-12-18 Advanced Cell Technology Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
DK3363902T3 (da) * 2012-12-06 2020-01-02 Sigma Aldrich Co Llc Crispr-baseret genommodifikation og -regulering
WO2014186686A2 (en) * 2013-05-17 2014-11-20 Two Blades Foundation Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
AU2014310360B2 (en) * 2013-06-11 2019-10-24 PPL (BVI) Limited Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
JP6793547B2 (ja) * 2013-12-12 2020-12-02 ザ・ブロード・インスティテュート・インコーポレイテッド 最適化機能CRISPR−Cas系による配列操作のための系、方法および組成物
AU2015219339B2 (en) * 2014-02-19 2020-03-05 Bioasis Technologies Inc. P97-IDS fusion proteins
EP3981876A1 (en) 2014-03-26 2022-04-13 Editas Medicine, Inc. Crispr/cas-related methods and compositions for treating sickle cell disease
EP3845655B1 (en) 2014-10-01 2025-01-01 The General Hospital Corporation Methods for increasing efficiency of nuclease-induced homology-directed repair
EP3313445A1 (en) 2015-06-24 2018-05-02 Sigma Aldrich Co. LLC Cell cycle dependent genome regulation and modification
JP6867689B2 (ja) * 2016-01-29 2021-05-12 国立大学法人東京工業大学 Cas9−gRNA複合体の細胞核内への導入方法、及び細胞内における標的遺伝子の改変方法
WO2017173004A1 (en) * 2016-03-30 2017-10-05 Mikuni Takayasu A method for in vivo precise genome editing
US11236313B2 (en) 2016-04-13 2022-02-01 Editas Medicine, Inc. Cas9 fusion molecules, gene editing systems, and methods of use thereof
CN107579793A (zh) * 2016-07-04 2018-01-12 中兴通讯股份有限公司 一种通信网络设备间时间同步的优化方法、装置及设备
WO2018027078A1 (en) * 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
AU2017308889B2 (en) 2016-08-09 2023-11-09 President And Fellows Of Harvard College Programmable Cas9-recombinase fusion proteins and uses thereof
KR20240007715A (ko) * 2016-10-14 2024-01-16 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
US11242513B2 (en) 2016-12-14 2022-02-08 Wageningen Universiteit Thermostable Cas9 nucleases
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
CA3071769A1 (en) 2017-07-31 2019-02-07 Reflection Biotechnologies Limited Cellular models of and therapies for ocular diseases
US11071791B2 (en) * 2018-01-26 2021-07-27 Wisconsin Alumni Research Foundation Vector for gene silencing and replacement and methods of use thereof
WO2019161290A1 (en) 2018-02-15 2019-08-22 Sigma-Aldrich Co. Llc Engineered cas9 systems for eukaryotic genome modification
PL3765615T3 (pl) * 2018-03-14 2023-11-13 Arbor Biotechnologies, Inc. Nowe enzymy i układy crispr ukierunkowane na dna
SG11202108812SA (en) 2019-02-15 2021-09-29 Sigma Aldrich Co Llc Crispr/cas fusion proteins and systems

Similar Documents

Publication Publication Date Title
JP2023541400A5 (cg-RX-API-DMAC10.html)
IL321024A (en) Engineered CAS9 Systems For Eukaryotic Genome Modification
AU2026201309A1 (en) Compositions and methods for gene editing
JP2023517294A5 (cg-RX-API-DMAC10.html)
CN113373130A (zh) Cas12蛋白、含有Cas12蛋白的基因编辑系统及应用
US20160138046A1 (en) Compositions and methods directed to crispr/cas genomic engineering systems
JP2022547524A5 (cg-RX-API-DMAC10.html)
KR20240055073A (ko) 클래스 ii, v형 crispr 시스템
US20230235306A1 (en) Argonaute protein from eukaryotes and application thereof
JP2024524514A5 (cg-RX-API-DMAC10.html)
JP2024511621A5 (cg-RX-API-DMAC10.html)
JP2026074192A (ja) Crisprタンパク質をコードする合成自己複製rnaベクターおよびその使用
Perriman et al. Effective ribozyme delivery in plant cells.
WO2020124319A1 (zh) 融合蛋白及其应用
CN107245493A (zh) 一种表达受茶碱调控的适体核酶修饰型sgRNA的载体及应用
IL323575A (en) Isolated nuclease and its use
CN104630229B (zh) 一种具有启动子功能的dna片段与应用
CN106086025A (zh) 一种具有启动子功能的dna片段及其应用
US5863730A (en) Procedure for the polymerization of nucleic acid sequences and its applications
JP2025535373A5 (cg-RX-API-DMAC10.html)
US9701981B2 (en) Nucleosome-excluding sequences (NES) as a DNA spacer in vectors results in prolonged transgene expression in eukaryotic cells
CN102296087B (zh) 基于枯草芽孢杆菌生物素连接酶的外源基因诱导表达调控系统及其构建方法
WO2022075419A1 (ja) Crisprタイプi-dシステムを利用した標的ヌクレオチド配列改変技術
JP4665190B2 (ja) 遺伝子の転写調節方法
CN121006344B (zh) 核酸酶TnpB的突变体及其制备方法和应用